Novo Holdings and TA Associates back Biocomposites
Danish asset manager Novo Holdings, which is owned by Novo Nordisk Foundation (NNF), the majority voting shareholder of pharmaceuticals giant Novo Nordisk, is investing in Biocomposites alongside existing shareholder TA Associates. The post Novo Holdings and TA Associates back Biocomposites appeared first on Medical Device Network.
Danish asset manager Novo Holdings, which is owned by Novo Nordisk Foundation (NNF), the majority voting shareholder of pharmaceuticals giant Novo Nordisk, is investing in Biocomposites alongside existing shareholder TA Associates.
The post Novo Holdings and TA Associates back Biocomposites appeared first on Medical Device Network.
